| Vernon A Rayford, MD | |
|
845 S Madison St, Tupelo, MS 38801-4905 | |
| (662) 377-5930 | |
| Not Available |
| Full Name | Vernon A Rayford |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 845 S Madison St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053548545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | L-240222 (Massachusetts) | Secondary |
| 207R00000X | Internal Medicine | 22631 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Ctr Hha | Tupelo, MS | Home health agency |
| Kindred At Home | Tupelo, MS | Home health agency |
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Mississippi Medical Clinics Inc | 6103736665 | 113 |
| North Mississippi Medical Center Inc | 9931010600 | 295 |
News Archive
When a regular doctor is not at hospital due to illness or vacation, for example, patients are not treated by the doctor's colleague or other hospital physician, but by a locum from outside of the hospital. Researchers from Harvard Medical School have now asked whether these temps provide the same level of care as the doctors they are filling in for.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
› Verified 4 days ago
| Entity Name | North Mississippi Medical Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053469486 PECOS PAC ID: 6103736665 Enrollment ID: O20040127000582 |
News Archive
When a regular doctor is not at hospital due to illness or vacation, for example, patients are not treated by the doctor's colleague or other hospital physician, but by a locum from outside of the hospital. Researchers from Harvard Medical School have now asked whether these temps provide the same level of care as the doctors they are filling in for.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
› Verified 4 days ago
| Entity Name | North Mississippi Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972608347 PECOS PAC ID: 9931010600 Enrollment ID: O20040413000541 |
News Archive
When a regular doctor is not at hospital due to illness or vacation, for example, patients are not treated by the doctor's colleague or other hospital physician, but by a locum from outside of the hospital. Researchers from Harvard Medical School have now asked whether these temps provide the same level of care as the doctors they are filling in for.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
› Verified 4 days ago
| Entity Name | Clay County Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578670972 PECOS PAC ID: 4789649609 Enrollment ID: O20041119000718 |
News Archive
When a regular doctor is not at hospital due to illness or vacation, for example, patients are not treated by the doctor's colleague or other hospital physician, but by a locum from outside of the hospital. Researchers from Harvard Medical School have now asked whether these temps provide the same level of care as the doctors they are filling in for.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vernon A Rayford, MD 845 S Madison St, Tupelo, MS 38801-4905 Ph: (662) 377-5076 | Vernon A Rayford, MD 845 S Madison St, Tupelo, MS 38801-4905 Ph: (662) 377-5930 |
News Archive
When a regular doctor is not at hospital due to illness or vacation, for example, patients are not treated by the doctor's colleague or other hospital physician, but by a locum from outside of the hospital. Researchers from Harvard Medical School have now asked whether these temps provide the same level of care as the doctors they are filling in for.
Infusion of a combination therapy consisting of glucose, insulin, and potassium, which was thought could be a beneficial treatment immediately following a heart attack, may increase the risk of heart failure and death in the first 3 days for patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack), according to a study in the November 28 issue of JAMA: The Journal of the American Medical Association.
ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
As part of their ongoing growth strategy, Radiant has been expanding its capabilities into the Consumer Products Testing arena. In order to supplement the existing Radiant staff that has years of consumer products testing experience, Radiant has hired key technical experts to serve as Study Managers, and to assist in training and certification of personnel.
› Verified 4 days ago
Dr. Marcus Louis Britton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1542 Medical Park Cir, Tupelo, MS 38801 Phone: 662-844-4711 | |
John O Phillips, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Suite 201, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 | |
Dr. Michael Ted Boler Jr., D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste A2, Tupelo, MS 38801 Phone: 662-620-6800 Fax: 662-620-6950 | |
Christy Tucker Oswalt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 S Thomas St, Tupelo, MS 38801 Phone: 662-842-7870 Fax: 662-842-7873 | |
Stephen T Amann, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 589 Garfield St, Tupelo, MS 38801 Phone: 662-680-5565 Fax: 662-680-5654 | |
Douglas L Hill, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste A2, Cardiology Associates Of North Ms, Tupelo, MS 38801 Phone: 662-620-6800 Fax: 662-620-6920 |